Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune system responses in Parkinson's disease: Early and dynamic
Malú G. Tansey, Marina Romero‐Ramos
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 364-383
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Marta Pajares, Ana I. Rojo, Gina Manda, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1687-1687
Open Access | Times Cited: 561
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson’s disease
Jordi Galiano-Landeira, Albert Torra, Miquel Vila, et al.
Brain (2020) Vol. 143, Iss. 12, pp. 3717-3733
Open Access | Times Cited: 176
The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
Adina N. MacMahon Copas, Sarah F. McComish, Jean M. Fletcher, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 128
The Glymphatic System (En)during Inflammation
Frida Lind‐Holm Mogensen, Christine Delle, Maiken Nedergaard
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7491-7491
Open Access | Times Cited: 124
Epidemiology of Parkinson’s Disease: An Update
Juan R. Deliz, Caroline M. Tanner, Paulina Gonzàlez‐Latapi
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 6, pp. 163-179
Closed Access | Times Cited: 17
Implications of the Gut Microbiome in Parkinson's Disease
Mohamed Elfil, Serageldin Kamel, Mohamed Kandil, et al.
Movement Disorders (2020) Vol. 35, Iss. 6, pp. 921-933
Closed Access | Times Cited: 130
Alterations in Blood Monocyte Functions in Parkinson's Disease
Sara Konstantin Nissen, Kalpana Shrivastava, Claudia Schulte, et al.
Movement Disorders (2019) Vol. 34, Iss. 11, pp. 1711-1721
Closed Access | Times Cited: 78
TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
Anastazja M. Gorecki, Chidozie C. Anyaegbu, Ryan S. Anderton
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 72
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Xin Zang, Si Chen, Junyao Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 63
Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's Disease
Laura Muñoz‐Delgado, Daniel Macías‐García, Silvia Jesús, et al.
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2426-2430
Closed Access | Times Cited: 62
Fine mapping of the HLA locus in Parkinson’s disease in Europeans
Eric Yu, Aditya Ambati, Maren Stolp Andersen, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
Pierre Garcia, Wiebke M. Wemheuer, Oihane Uriarte Huarte, et al.
Glia (2022) Vol. 70, Iss. 5, pp. 935-960
Open Access | Times Cited: 54
Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
Elodie Kip, Louise C. Parr‐Brownlie
Ageing Research Reviews (2022) Vol. 78, pp. 101618-101618
Open Access | Times Cited: 53
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Enquan Xu, Ravindra Boddu, Hisham Abdelmotilib, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 48
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Recent Advances in Drug Therapy for Parkinson's Disease
Hidetomo Murakami, Tomotaka Shiraishi, Tadashi Umehara, et al.
Internal Medicine (2022) Vol. 62, Iss. 1, pp. 33-42
Open Access | Times Cited: 39
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Levodopa-loaded nanoparticles for the treatment of Parkinson's disease
Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 212-224
Open Access | Times Cited: 29
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson’s disease
Fangyi Li, Guomei Weng, Hang Zhou, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 11
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
Zhen Zhang, Kun Niu, Taoying Huang, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Peripherally administered TNF inhibitor is not protective against α-synuclein-induced dopaminergic neuronal death in rats
Josefine Rågård Christiansen, Sara A. Ferreira, David E. Szymkowski, et al.
Neurobiology of Disease (2025), pp. 106803-106803
Open Access | Times Cited: 1
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
Arianna Bellucci, Luigi Bubacco, Francesca Longhena, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 69
Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
Anarmaa Mendsaikhan, Ikuo Tooyama, Douglas G. Walker
Cells (2019) Vol. 8, Iss. 3, pp. 230-230
Open Access | Times Cited: 64
Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease
Elena Vacchi, Jacopo Burrello, Dario Di Silvestre, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 7, Iss. 6
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top